A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate

Antibody-drug conjugates (ADCs) are being developed worldwide with the potential to revolutionize current cancer treatment strategies. Developing novel theranostic ADCs with therapeutic utility and imaging capability is an attractive and challenging subject that promises advances in the field of per...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Dian, Zhao, Lei, Xie, Fei, Fan, Shiyong, Liu, Lianqi, Li, Wei, Cao, Ruiyuan, Li, Song, Zhong, Wu, Zhou, Xinbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806464/
https://www.ncbi.nlm.nih.gov/pubmed/33456559
http://dx.doi.org/10.7150/thno.51232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806464/
https://www.ncbi.nlm.nih.gov/pubmed/33456559
http://dx.doi.org/10.7150/thno.51232

Ejemplares similares